Celgene engages in the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory-related diseases in the United States. It operates in two segments: Human Pharmaceuticals and Stem Cell Therapies.
| Registrars: |
| Address: | |
| Phone: | |
| Fax: | |
| Website: | |
| Email: |
| ISIN: | US1510201049 |
| Main Indices: | S&P 500, Nasdaq 100, Nasdaq Composite, S&P 100 |